Literature DB >> 14043989

IN VITRO BIOLOGICAL ACTIVITY OF CEPHALOTHIN.

T W CHANG, L WEINSTEIN.   

Abstract

Chang, Te-Wen (Tufts University School of Medicine, Boston, Mass.) and Louis Weinstein. In vitro biological activity of cephalothin. J. Bacteriol. 85:1022-1027. 1963.-Cephalothin is a "broad-spectrum" antibiotic active, in low concentrations, against Diplococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Shigella, Salmonella, and Proteus mirabilis were the most sensitive of the gram-negative organisms. Escherichia coli and Aerobacter aerogenes were suppressed to a lesser degree, whereas Pseudomonas aeruginosa and Herellea were highly resistant. Penicillin-sensitive and -resistant strains of S. aureus were equally susceptible to cephalothin. Exposure to increasing concentrations of the drug very frequently led to the development of resistance in gram-negative organisms; this was observed less often with S. aureus. Cephalothin stimulated the production of penicillinase by staphylococci, which remained sensitive to the cephalosporanic acid derivatives despite repeated subculture in increasing concentrations of the agent. Cephalothin was not inhibited by penicillinase. This antibiotic was more toxic to cultures of human amnion and mouse embryo cells than benzyl penicillin G but was less injurious than oxytetracycline, chlortetracycline, and demethylchlortetracycline; tetracylcine produced about the same degree of cellular damage as cephalothin.

Entities:  

Keywords:  AEROBACTER AEROGENES; ANTIBIOTICS; CANDIDA; CRYPTOCOCCUS; DIPLOCOCCUS PNEUMONIAE; ECHO VIRUSES; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; HERPESVIRUS HOMINIS; MIMAE; PENICILLIN; PENICILLINASE; POLIOVIRUS; PROTEUS; PSEUDOMONAS AERUGINOSA; SALMONELLA; SHIGELLA; STAPHYLOCOCCUS; STREPTOCOCCUS

Mesh:

Substances:

Year:  1963        PMID: 14043989      PMCID: PMC278278          DOI: 10.1128/jb.85.5.1022-1027.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  4 in total

1.  Cephalosporin N: a new type of penicillin.

Authors:  E P ABRAHAM; G G F NEWTON; K CRAWFORD; H S BURTON; C W HALE
Journal:  Nature       Date:  1953-02-21       Impact factor: 49.962

2.  Isolation of antibiotics from a species of Cephalosporium; cephalosporins P1, P2, P3, P4, and P5.

Authors:  H S BURTON; E P ABRAHAM
Journal:  Biochem J       Date:  1951-12       Impact factor: 3.857

3.  Antibiotic production by a species of Cephalosporium.

Authors:  K CRAWFORD; N G HEATLEY; P F BOYD; C W HALE; B K KELLEY; G A MILLER; N SMITH
Journal:  J Gen Microbiol       Date:  1952-02

4.  Modified Gots test for penicillinase production.

Authors:  T H HAIGHT; M FINLAND
Journal:  Am J Clin Pathol       Date:  1952-08       Impact factor: 2.493

  4 in total
  7 in total

1.  Use of Cephalosporinase in Blood Cultures.

Authors:  T W Chang; L Weinstein
Journal:  J Bacteriol       Date:  1965-09       Impact factor: 3.490

2.  In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.

Authors:  A Vuye; J Pijck; H Soep
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

3.  Cephapirin: in vitro antibacterial spectrum.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  Appl Microbiol       Date:  1971-11

4.  SENSITIVITY OF COCCAL AND L FORMS OF STAPHYLOCOCCUS AUREUS TO FIVE ANTIBIOTICS.

Authors:  B M KAGAN; S ZOLLA; R BUSSER; S LIEPNIEKS
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

5.  INDUCTION BY ANTIBIOTICS AND COMPARATIVE SENSITIVITY OF L-PHASE VARIANTS OF STAPHYLOCOCCUS AUREUS.

Authors:  C W MOLANDER; B M KAGAN; H J WEINBERGER; E M HEIMLICH; R J BUSSER
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

6.  MORPHOLOGICAL CHANGES IN GRAM-NEGATIVE BACILLI EXPOSED TO CEPHALOTHIN.

Authors:  T W CHANG; L WEINSTEIN
Journal:  J Bacteriol       Date:  1964-12       Impact factor: 3.490

Review 7.  The cephalosporins: activity and clinical use.

Authors:  A J Weinstein
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.